YOLFTbeta
03

Solborn Inc

035610 · KQ · Industrials / Conglomerates

5,050.00KRW+50.00 (+1.00%)

Price History

Full chart

Market Stats

Previous Close5,000.00
Open4,950.00
Day Range4,950.00 – 5,150.00
52-Week Range3,155.00 – 5,600.00
Volume7.13K
Market Cap134.41B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.78
50-Day Avg4,915.00
200-Day Avg3,995.48

About

Solborn, Inc., an investment holding company, engages in the manufacturing and sales of medical equipment in South Korea. The company engages in the PACS and S/W manufacturing, sales, and maintenance; medical device H/W manufacturing, wholesale, and maintenance. It is also involved in provision of newspaper issuance and online information services. In addition, the company invests in small and medium-sized enterprises and venture companies. Further, it engages in golf related business and real estate leasing business. The company was formerly known as Serome Technology, Inc. Solborn, Inc. was founded in 1994 and is headquartered in Seoul, South Korea.

Company Details

  • SectorIndustrials
  • IndustryConglomerates
  • CEOMr. Gi-Tae Hong
  • Employees10
  • Headquarters66-4, Cheongdam-dong, Seoul, South Korea, Korea
  • Websitehttps://www.solborn.co.kr

Leadership

  • Mr. Gi-Tae HongChairman & CEO · b. 1957
  • Mr. Hae-Gu YuDirector of Business Administration Division · b. 1968
  • Ms. Hye-Suk LeeVP & Director · b. 1965

Financials

Income Statement

Currency: KRW2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue45.64B29.20B65.58B98.15B103.28B137.45B117.05B116.80B87.88B92.48B153.95B148.98B98.53B71.64B70.50B74.49B74.11B84.44B80.31B82.04B100.20B93.82B119.84B121.90B120.65B
Growth (%)--36.03%+124.63%+49.66%+5.22%+33.09%-14.84%-0.21%-24.77%+5.24%+66.47%-3.23%-33.86%-27.29%-1.59%+5.66%-0.51%+13.94%-4.89%+2.15%+22.14%-6.37%+27.74%+1.72%-1.03%
Cost of Revenue57.41B24.20B42.41B70.51B57.74B80.62B73.95B-45.45B54.55B86.50B82.44B45.97B30.86B27.25B32.60B34.05B29.90B37.81B37.01B44.45B70.89B38.94B40.33B40.96B
Gross Profit-------------40.03B43.25B41.89B40.06B54.54B42.50B45.03B55.75B22.93B80.90B81.57B79.69B
Gross Margin-------------55.88%61.34%56.24%54.05%64.59%52.92%54.89%55.64%24.44%67.51%66.92%66.05%
Operating Expense-------------41.93B42.64B36.02B37.79B43.02B39.69B36.27B40.09B49.77B47.02B55.48B55.07B
Operating Income-----3.91B--8.63B---420.84M-1.90B603.50M5.87B2.26B11.52B2.82B8.76B15.66B-26.84B33.88B26.09B24.62B
Operating Margin-----2.84%--9.82%---0.43%-2.65%0.86%7.88%3.05%13.64%3.51%10.68%15.63%-28.61%28.27%21.40%20.41%
EBITDA----------------------42.48B55.18B67.21B49.28B
EBITDA Margin----------------------45.28%46.04%55.13%40.85%
Net Income--2.54B--9.25B--4.08B---3.27B5.27B1.49B387.21M-5.64B9.93B1.78B1.45B17.82B-41.71B38.25B36.92B20.87B
Net Income Margin--3.87%--6.73%--4.65%---3.32%7.36%2.11%0.52%-7.61%11.77%2.21%1.76%17.79%-44.46%31.92%30.29%17.30%
R&D----------3.67B-9.11B6.27B3.05B4.32B5.15B6.78B6.81B5.76B7.38B8.04B8.64B9.21B7.75B
R&D as % of Total Revenue----------2.38%-9.24%8.75%4.32%5.80%6.94%8.03%8.47%7.02%7.36%8.57%7.21%7.55%6.42%
Interest Expense0000000000000000000141.16M115.23M124.97M133.52M133.33M106.70M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.17%0.12%0.13%0.11%0.11%0.09%

Balance Sheet

Currency: KRW2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets295.95B263.48B292.34B252.53B248.16B215.57B194.21B169.97B169.11B176.84B214.11B196.39B183.39B180.34B187.54B191.34B187.44B197.27B208.15B217.81B256.07B220.67B275.84B351.35B374.53B
Total Liabilities14.88B24.54B61.26B49.40B87.18B44.31B50.97B38.73B30.07B31.54B66.09B51.72B31.30B24.93B58.77B62.48B59.93B58.51B67.86B79.13B94.47B96.83B111.10B144.85B62.64B
Total Equity281.07B220.97B224.61B197.56B146.13B150.41B126.40B116.83B123.31B115.45B116.63B116.21B120.08B123.54B128.76B128.86B127.51B138.76B140.28B138.68B161.60B123.84B164.74B206.50B212.61B
Cash81.71B91.29B36.48B28.72B27.52B20.63B14.38B12.83B23.09B28.01B33.14B27.79B54.47B49.87B48.75B49.40B29.51B17.11B22.82B40.92B1.22M1.22M342.42M1.22M22.72B
Total Debt--------------6.75B---2.93B2.56B-----

Cash Flow

Currency: KRW2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--4.10B-8.96B198.51M7.03B7.30B-6.43B5.44B14.99B1.43B7.00B1.33B3.85B5.71B13.67B17.77B15.83B14.84B11.22B15.31B15.07B
Investing Cash Flow11.69B-6.23B50.73B5.60B--5.68B3.98B--17.41B-6.10B-7.57B-364.79M-25.67B-14.71B-7.82B2.68B-39.48B5.93B-27.81B-12.07B-
Financing Cash Flow4.30B------845.02M12.79B2.30B---392.16M82.75M398.49M1.90B-5.28B-1.64B-928.82M-1.82B-2.70B-1.49B-3.33B-
Capital Expenditure2.01B31.16B1.71B9.18B3.98B6.22B1.87B1.06B3.97B5.68B4.40B1.15B850.30M3.25B2.15B1.06B439.44M1.65B1.20B804.36M475.99M719.66M427.14M527.51M
Free Cash Flow------------------16.44B14.63B14.31B10.50B14.88B14.55B
Dividends Paid----------30.00M------------1.25B
FCF to OCF------------------92.54%92.46%96.43%93.58%97.21%96.50%
Dividend Paid to FCF-----------------------8.59%

Earnings

Report DateAug 31, 2011Nov 30, 2011Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013May 28, 2014Sep 3, 2014Dec 3, 2014Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016Aug 31, 2016Nov 30, 2016Mar 1, 2017May 31, 2017Aug 30, 2017Nov 29, 2017Feb 28, 2018May 30, 2018Aug 13, 2018Nov 28, 2018Feb 27, 2019May 29, 2019Aug 12, 2019Nov 13, 2019Feb 26, 2020May 8, 2020Aug 18, 2020Nov 11, 2020Mar 26, 2021May 14, 2021Aug 13, 2021Nov 17, 2021May 13, 2022Aug 12, 2022Nov 11, 2022Mar 1, 2023May 12, 2023Aug 15, 2023Nov 15, 2023Mar 29, 2024May 10, 2024Aug 14, 2024Nov 13, 2024Mar 28, 2025Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------------------------
EPS Actual-40.1849.8518.91162.1819.88117.08-14.49-12.17-41.68221.15250.779.2353.10-221.58-29.71127.38-48.99-28.37-22.26-78.0328.53-171.828.30-16.15-7.34403.1525.97256.1514.13-219.41-381.78396.46-23.9864.69824.3816.2083.51-180.70-489.32-15.57-1025.90362.77537.38100.60713.64399.04451.38114.30599.99-391.56901.54575.94-205.7256.29965.98
Surprise-------------------------------------------------------
Timing-------------------------------------------------------

Key Statistics & Ratios

Market Cap134.41B
Enterprise Value-77.22B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.07
Price / Book0.57
Revenue (TTM)125.03B
Gross Profit (TTM)82.92B
EBITDA30.31B
Profit Margin27.90%
Operating Margin45.87%
Return on Equity20.59%
Return on Assets4.40%
Shares Outstanding27.35M
Shares Float279.00K
Beta0.78
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jul 4, 20059997:13329